Physician profile
Morgan L Fields
NPI 1376273730
$2,282.90
in general payments reported to CMS, 2019-2025
22 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $233 · 2023: $1,021 · 2024: $740 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,050.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $501.26 | 2022-2025 | Leqvio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $382.94 | 2023-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $218.51 | 2023-2024 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.00 | 2022-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $139.79 | 2023-2025 | Camzyos, Eliquis |
| Atricure, INC. | $124.72 | 2023 | |
| Merck Sharp & Dohme LLC | $116.26 | 2022-2024 | Verquvo |
| Medtronic, INC. | $107.65 | 2023 | Micra |
| Amgen INC. | $92.90 | 2023-2024 | Repatha |
| Pfizer INC. | $86.31 | 2023-2024 | |
| Daxor Corporation | $52.87 | 2022-2023 | Bva-100 |
| Chiesi USA, INC. | $46.90 | 2022-2024 | Cleviprex, Kengreal |
| Heartflow, INC. | $46.88 | 2023-2024 | Ffrct |
| Scpharmaceuticals INC. | $35.93 | 2023-2024 | |
| Boston Scientific Corporation | $25.57 | 2024 | Watchman Flx |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $23.01 | 2022 | |
| Inspire Medical Systems, INC. | $21.08 | 2025 | Inspire |
| Nuwellis, INC. | $20.93 | 2023 | Aquadex Smartflow Console |
| Philips North America LLC | $19.35 | 2024 | (Ck4) Mcot |
| Novo Nordisk INC | $19.11 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.03 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.90 | 2024 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.